Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XR-B vs XR-NTX for OUD in CJS-involved Adults
NCT04219540Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Jan 2021
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of buprenorphine extended-release injection in opioid use disorder (OUD), sponsored by NYU Langone Health. Started Jan 2021; status: completed.
02
Drugs
buprenorphine extended-release injection
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04219540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04219540.